BSE filing, NSE: NORRIS. Summary written from the filing by ALFA Finder's alert engine.
Norris Medicines Ltd: key numbers
- Share price
- ₹15.37
- Market cap
- ₹15.37 Cr
- Revenue (annual)
- ₹8.13 Cr
- Net profit (annual)
- ₹-0.28 Cr
- P/E (TTM)
- -41.9×Sector 42.0×
- Promoter holding
- 34.01%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Norris Medicines Ltd
All →Norris Medicines Other Announcement
Norris Medicines Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Norris Medicines Annual General Meeting
Norris Medicines Limited held its 35th Annual General Meeting on September 29, 2026, where members transacted various ordinary and special business items.
Norris Medicines Annual Report
Norris Medicines Limited has filed its 35th Annual Report for the financial year 2025-26, including the notice of its upcoming Annual General Meeting.
Norris Medicines Annual General Meeting
Norris Medicines approved the Directors' Report, Annual Report, and convening of the 35th Annual General Meeting for September 29, 2026.
Norris Medicines Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens
Norris Medicines Ltd reported revenue from operations of ₹0.9 Cr (-40.0% YoY) and a net loss of ₹0.4 Cr for Q1 FY27.
- Key figure
- Net loss ₹0.4 Cr
Norris Medicines Board Meeting Date
Norris Medicines Limited has scheduled a board meeting for August 14, 2026, to consider and approve the un-audited financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →Innovative Tech Pack Board Meeting Date
Innovative Tech Pack will hold a board meeting on 13 November 2026 to consider unaudited standalone quarterly results. Trading window closed from 1 to 16 October 2026.
Fedders Holding Board Meeting Date
Fedders Holding will hold a board meeting on 14 November 2026 to consider half-yearly financial results for March 2026. Trading window remains closed until 16 November 2026.
Kesar Enterprises Board Meeting Date
Kesar Enterprises will hold a board meeting on 13 November 2026 to consider unaudited standalone half-yearly results. Trading window remains closed until 15 November 2026.
Ceinsys Tech Board Meeting Date
Ceinsys Tech schedules a 12 November 2026 board meeting to consider unaudited standalone and consolidated quarterly results for September 2026. Trading window closes from 1 October until 14 November 2026.
Udayshivakumar Infra Board Meeting Date
UdayShivakumar Infra schedules a 14 November 2026 board meeting to consider unaudited standalone quarterly results for September 2026. Trading window closes from 1 October until 16 November 2026.
Choksi Laboratories Board Meeting Date
Choksi Laboratories schedules a 14 November 2026 board meeting to consider unaudited standalone half-yearly results for September 2026. Trading window closes from 1 October until 16 November 2026.